nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Conjunctival hyperaemia—Prednisolone—ankylosing spondylitis	0.0495	0.0495	CcSEcCtD
Thiabendazole—Conjunctival hyperaemia—Betamethasone—ankylosing spondylitis	0.0413	0.0413	CcSEcCtD
Thiabendazole—Conjunctival hyperaemia—Dexamethasone—ankylosing spondylitis	0.0413	0.0413	CcSEcCtD
Thiabendazole—Visual acuity reduced—Betamethasone—ankylosing spondylitis	0.0305	0.0305	CcSEcCtD
Thiabendazole—Visual acuity reduced—Dexamethasone—ankylosing spondylitis	0.0305	0.0305	CcSEcCtD
Thiabendazole—Lymphadenopathy—Methotrexate—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Thiabendazole—Hepatic failure—Methotrexate—ankylosing spondylitis	0.0107	0.0107	CcSEcCtD
Thiabendazole—Visual impairment—Prednisolone—ankylosing spondylitis	0.0105	0.0105	CcSEcCtD
Thiabendazole—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Thiabendazole—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Thiabendazole—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00967	0.00967	CcSEcCtD
Thiabendazole—Vision blurred—Prednisolone—ankylosing spondylitis	0.00897	0.00897	CcSEcCtD
Thiabendazole—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00895	0.00895	CcSEcCtD
Thiabendazole—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00879	0.00879	CcSEcCtD
Thiabendazole—Visual impairment—Betamethasone—ankylosing spondylitis	0.00879	0.00879	CcSEcCtD
Thiabendazole—Angioedema—Prednisolone—ankylosing spondylitis	0.0087	0.0087	CcSEcCtD
Thiabendazole—Convulsion—Prednisolone—ankylosing spondylitis	0.00825	0.00825	CcSEcCtD
Thiabendazole—Angioedema—Triamcinolone—ankylosing spondylitis	0.008	0.008	CcSEcCtD
Thiabendazole—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00798	0.00798	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00777	0.00777	CcSEcCtD
Thiabendazole—Convulsion—Triamcinolone—ankylosing spondylitis	0.00758	0.00758	CcSEcCtD
Thiabendazole—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00757	0.00757	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—ankylosing spondylitis	0.0074	0.0074	CcSEcCtD
Thiabendazole—Flushing—Prednisone—ankylosing spondylitis	0.00737	0.00737	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00733	0.00733	CcSEcCtD
Thiabendazole—Angioedema—Betamethasone—ankylosing spondylitis	0.00726	0.00726	CcSEcCtD
Thiabendazole—Angioedema—Dexamethasone—ankylosing spondylitis	0.00726	0.00726	CcSEcCtD
Thiabendazole—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00719	0.00719	CcSEcCtD
Thiabendazole—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00714	0.00714	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00713	0.00713	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—ankylosing spondylitis	0.00705	0.00705	CcSEcCtD
Thiabendazole—Convulsion—Dexamethasone—ankylosing spondylitis	0.00688	0.00688	CcSEcCtD
Thiabendazole—Convulsion—Betamethasone—ankylosing spondylitis	0.00688	0.00688	CcSEcCtD
Thiabendazole—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00666	0.00666	CcSEcCtD
Thiabendazole—Vision blurred—Prednisone—ankylosing spondylitis	0.00652	0.00652	CcSEcCtD
Thiabendazole—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00648	0.00648	CcSEcCtD
Thiabendazole—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00648	0.00648	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0064	0.0064	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—ankylosing spondylitis	0.0064	0.0064	CcSEcCtD
Thiabendazole—Angioedema—Prednisone—ankylosing spondylitis	0.00632	0.00632	CcSEcCtD
Thiabendazole—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00629	0.00629	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00628	0.00628	CcSEcCtD
Thiabendazole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00627	0.00627	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—ankylosing spondylitis	0.00619	0.00619	CcSEcCtD
Thiabendazole—Anorexia—Betamethasone—ankylosing spondylitis	0.00618	0.00618	CcSEcCtD
Thiabendazole—Anorexia—Dexamethasone—ankylosing spondylitis	0.00618	0.00618	CcSEcCtD
Thiabendazole—Fatigue—Triamcinolone—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Thiabendazole—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00615	0.00615	CcSEcCtD
Thiabendazole—Hypotension—Betamethasone—ankylosing spondylitis	0.00606	0.00606	CcSEcCtD
Thiabendazole—Hypotension—Dexamethasone—ankylosing spondylitis	0.00606	0.00606	CcSEcCtD
Thiabendazole—Convulsion—Prednisone—ankylosing spondylitis	0.00599	0.00599	CcSEcCtD
Thiabendazole—Chills—Methotrexate—ankylosing spondylitis	0.00596	0.00596	CcSEcCtD
Thiabendazole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Thiabendazole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00587	0.00587	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00583	0.00583	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Thiabendazole—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00571	0.00571	CcSEcCtD
Thiabendazole—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00571	0.00571	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Thiabendazole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Thiabendazole—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Thiabendazole—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Thiabendazole—Fatigue—Dexamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Thiabendazole—Fatigue—Betamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—ankylosing spondylitis	0.00545	0.00545	CcSEcCtD
Thiabendazole—Anorexia—Prednisone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Thiabendazole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Thiabendazole—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Thiabendazole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00526	0.00526	CcSEcCtD
Thiabendazole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00525	0.00525	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Thiabendazole—Dizziness—Prednisolone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Thiabendazole—Asthenia—Triamcinolone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Thiabendazole—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Thiabendazole—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Thiabendazole—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00511	0.00511	CcSEcCtD
Thiabendazole—Pruritus—Triamcinolone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Thiabendazole—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—ankylosing spondylitis	0.00501	0.00501	CcSEcCtD
Thiabendazole—Dyspepsia—Prednisone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Thiabendazole—Decreased appetite—Prednisone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Thiabendazole—Rash—Prednisolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Thiabendazole—Dermatitis—Prednisolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Thiabendazole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Thiabendazole—Fatigue—Prednisone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Thiabendazole—Headache—Prednisolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Thiabendazole—Confusional state—Methotrexate—ankylosing spondylitis	0.00476	0.00476	CcSEcCtD
Thiabendazole—Dizziness—Triamcinolone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Thiabendazole—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Thiabendazole—Asthenia—Betamethasone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Thiabendazole—Asthenia—Dexamethasone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Thiabendazole—Nausea—Prednisolone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Thiabendazole—Pruritus—Dexamethasone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Thiabendazole—Pruritus—Betamethasone—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Thiabendazole—Vomiting—Triamcinolone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Thiabendazole—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Thiabendazole—Rash—Triamcinolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Thiabendazole—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Thiabendazole—Rash—Methylprednisolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Thiabendazole—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Thiabendazole—Headache—Triamcinolone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Thiabendazole—Headache—Methylprednisolone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Thiabendazole—Abdominal pain—Prednisone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Thiabendazole—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Thiabendazole—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Thiabendazole—Dizziness—Dexamethasone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Thiabendazole—Dizziness—Betamethasone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Thiabendazole—Nausea—Triamcinolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Thiabendazole—Nausea—Methylprednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Thiabendazole—Vomiting—Betamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Thiabendazole—Vomiting—Dexamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Thiabendazole—Rash—Dexamethasone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Thiabendazole—Rash—Betamethasone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Thiabendazole—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Thiabendazole—Dermatitis—Betamethasone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Thiabendazole—Headache—Betamethasone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Thiabendazole—Headache—Dexamethasone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Thiabendazole—Asthenia—Prednisone—ankylosing spondylitis	0.00405	0.00405	CcSEcCtD
Thiabendazole—Pruritus—Prednisone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Thiabendazole—Diarrhoea—Prednisone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Thiabendazole—Nausea—Betamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Thiabendazole—Nausea—Dexamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Thiabendazole—Dizziness—Prednisone—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Thiabendazole—Vomiting—Prednisone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Thiabendazole—Rash—Prednisone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Thiabendazole—Dermatitis—Prednisone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Thiabendazole—Headache—Prednisone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Thiabendazole—Asthenia—Methotrexate—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Thiabendazole—Nausea—Prednisone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Thiabendazole—Rash—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Thiabendazole—Headache—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Thiabendazole—Nausea—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
